Tag
Dr. Bhaskara Rao Bollineni
3 articles
KIMS FY26 Revenue Up 28% to ₹39,308 Million Amid Expansion
KIMS reported 28.2% revenue growth to ₹39,308 Mn in FY26 while expanding to 26 hospitals across 5 states with 8,600+ beds.
EBITDA reached ₹8,282 Mn (21.1% margin) despite PAT declining 41.7% to ₹2,420
KIMS Q1 FY27 Revenue Up 36% YoY to ₹11.96B
KIMS reported Q1 FY27 standalone & consolidated results with total revenue of ₹11,959 million, up 36.1% YoY, driven by strong volume growth.
EBITDA reached ₹2,398 million with a 20.1% margin, while PA
Crescentis Promoters Transfer 1.76% via Gift
Crescentis Capital discloses inter-se promoter share transfer of 300,000 shares (1.76%) via gift under SEBI Regulation 29(2).
Dr. Bhaskara Rao Bollineni gifted shares to Mr. Bhavanam Ruthvik Reddy on